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Abstract: We assessed the use of a filler compound together with the osteoinductive demineralized bone matrix (DBM), 
Colloss E. The filler was comprised of carboxymethyl-cellulose and collagen type 1. The purpose of the study was to see 
if the filler compound would enhance the bone formation and distribute the osteoinductive stimulus throughout the bone 
defect. Six sheep underwent a bilateral humerus drill defect. The drill hole was filled with a compound consisting of  
100 mg CMC, 100 mg collagen powder, and 1 ccm autologous full blood in one side, and a combination of this filler 
compound and 20 mg Colloss E in the other. The animals were divided into three groups of two animals and observed for 
8, 12 and 16 weeks. Drill holes was evaluated using quantitative computed tomography (QCT), micro computed 
tomography (CT) and histomorphometry. Mean total bone mineral density (BMD) of each implantation site was 
calculated with both QCT and CT. Bone volume to total volume (BV/TV) was analyzed using CT and 
histomorphometry. Although not statistically significant, results showed increased bone BMD after 16 weeks in CT data 
and an increased BV/TV after 16 weeks in both CT and histology. Correlation between QCT and CT was R
2 = 0.804. 
Correlation between histomorphometry and CT BV/TV data was R
2 = 0.8935 and with an average overrepresentation of 
8.2% in histomorphometry. In conclusion the CMC-Collagen + Colloss E filler seems like a viable osteogenic bone filler 
mid- to long term. A correlation was found between the analytical methods used in this study. 
Keywords: Collagen, histomorphometry, equine bone lyophilisate, cellulose. 
INTRODUCTION 
  Autograft is currently the gold standard for enhancing 
bone repair, although its use is associated with donor site 
morbidity and limited availability [1, 2]. Besides autograft, 
banked allograft bone is among the most commonly used 
osteoconductive and osteoinductive graft materials. Allograft 
however, holds the risk of infectious disease transmission, 
and may provoke an adverse immune response despite 
different processing and preservation methods [3-5]. This 
has led to numerous osteoinductive bone graft substitutes 
which vary from single growth factors, such as recombinant 
human bone morphogenetic protein-2 (rhBMP-2) to 
compounds containing native growth factors within collagen 
matrixes derived from demineralized bone matrix (DBM). 
rhBMP-2 has proven favorable osteoinductive properties, 
with fast bone regeneration in different orthopedic 
procedures, but recent studies have shown some undesired 
side effects when rhBMP-2 is used [6-9]. Safety concerns 
have been reported, due to formation of edemas, accelerated 
bone resorption and excessive bone formation [10-13]. 
  Colloss E, a lyophilized complex of extracellular matrix 
extracted from diaphyseal equine bone, has in recent studies 
shown to contain mainly collagen type I collagen matrix and  
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other proteins like BMP-2, BMP-3, BMP-7, transforming 
growth factor-1 and 2, vascular endothelial growth factor 
and insulin-like growth factor-1 [14]. It is extracted from 
healthy homogenous bone tissue and does therefore not vary 
in quality. The osteoinductive potential from a bovine 
equivalent (Colloss) was demonstrated in an ectopic rat 
model, and later Colloss E was proven osteogenic in a 
porcine spine model [15, 16]. Succeeding studies have 
shown its effectiveness as an alternative to bone grafts in 
experimental animal models for long bone repair in sheep, 
hip implant fixation in dogs, and in an anterior lumbar 
interbody fusion (ALIF) in a porcine model [17-21]. 
Furthermore, it has shown improved implant fixation when 
combined with -TCP granules in a dog hip model [22]. 
  The bone formation stimulated by Colloss E is known to 
have similar regenerative metabolic pattern compared to the 
gold standard graft material, autograft. The bone formation 
has shown to initiate from the periphery of the defect and 
inwards, unlike rhBMP-2 where a faster and more 
widespread ossification is observed [23]. We hypothesize 
this to be the result of the physical nature of the cotton-like 
texture of Colloss E, which plasters the matrix to the edges 
of the bone void. The main aim of this study was to analyze 
the bone formation when Colloss E was mixed with 
biocompatible and fast resorbable filler so the osteogenic 
effect would take effect throughout the bone void. Secondly 
the aim was to compare some of the most commonly 
employed tools in current experimental bone reconstructive 
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MATERIAL AND METHODS 
  Colloss E and custom prepared collagen from equine 
tendons were acquired from Ossacur AG, Oberstenfeld, 
Germany. Blanose
® CMC  7H4XF was bought from Hercules 
BV, Zwijndrecht, The Netherlands. Colloss E
® is a collagenous 
matrix consisting of Type I collagen chains with various other 
insoluble proteins including BMP-2 (2.6 mg/g), BMP-7 (3.8 
mg/g), TGF-ß1 (55 mg/g) and IGF 1 (2.9 mg/g) [24]. Blanose
® 
consists of Carboxymethyl cellulose (CMC), a cellulose 
derivative used primarily because of its high viscosity, non-
toxicity, and non-inflammatory properties. 
  The CMC-Collagen powder was packed in sterile vials 
containing 100 mg CMC and 100 mg Collagen powder. For 
the control defects, one CMC-Collagen vial was mixed with 
1 ccm autologous whole blood giving 1 ccm substance 
hereafter described as CMC-C. For the intervention defects, 
one CMC-Collagen vial was mixed with 1 vial Colloss E (20 
mg) and thereafter 1 ccm autologous whole blood giving 1 
ccm CMC-C with Colloss E. 
  A total of 6 skeletally mature female landrace sheep 
underwent treatment under the experimental protocol 
approved by the Danish National Animal Care and Use 
Committee. Step-by-step illustration of the surgery 
procedure is illustrated in Fig. (1). Prior to surgery, the sheep 
were fasted for two days and kept without water for one day 
to avoid aspiration during surgery. Under standard aseptic 
surgical technique and in general anaesthesia with 2% 
Isoflurane (Abbott Scandinavia AB, Solna, Sweden) and 
Fentanyl 0.5 ml/hour (Haldid, Janssen-Cilag, Janssen 
Pharmaceutica, Beerse, Belgium), access to the proximal 
lateral humeri was made by a transdeltoid approach. On each 
proximal part of the humerus, the periost was split, elevated 
and withdrawn from the planned drill hole area. A 2 mm drill 
guide wire was inserted perpendicular to the cortical surface 
8 mm anterodistally to the greater tubercle. With the aid of a 
wire guide, another two 2 mm guide wires were placed 
parallel to the drill guide wire, but 8.5 mm proximal and 
distal to it and later cut at the cortical level. Over the 
remaining middle 2 mm drill guide wire, a 10 mm deep hole 
was drilled with a cannulated 11 mm diameter drill bit. After 
removal of the drill guide wire, the drill hole was irrigated 
with saline, and the CMC-C with or without Colloss E 
inserted into the defect. Periost, deltoid fascia, subcutis and 
subepidermal closure was done with resorbable 3-0 sutures, 
and skin closure was finalized with metal clips. The animals 
were kept in the University’s animal housing facility until 
termination date. Two animals were euthanatized at each 
time point of 8, 12 and 16 weeks postsurgery, using 1 ml 
xylazine (Rompun vet.
®, Bayer Austria, Vienna, Austria) (20 
mg/ml) and pentobarbital (50 mg/kg). The humerus was 
dissected free, frozen and stored at -20˚C immediately after 
retrieval. 
QCT Evaluation 
  QCT (quantitative computed tomography) was performed 
on the XCT 2000+ Research scanner (Stratec 
Medizintechnik GmbH, Pforzheim, Germany). The 
specimens were oriented in the scanner with the guide wires 
parallel to the scan plane verified by the scout view 
scanning. On the scout view image, the center of the drill 
hole was determined, and three scan planes were sampled: 
One through the center of the drill hole and one paracentral 
plane on each side of the central plane, 2 mm from the distal 
plane. On the three sampled scan planes a 10x10 mm ROI 
(region of interest) was superimposed on the images guided 
by the cortical edges and the drill guide wire canal in the 
bone (Fig. 1). For each of the ROI sizes, a mean total density 
of the tissue within the three sampled scan planes for each 
implantation site was calculated. 
 
Fig. (1). Graphical illustration of operation procedure. (a) 
Placement of guide wires perpendicular to the one surface and 
insertion of guide wires. (b) Cannulation of bone defect using 
cannulated drill bit. (c). Guide wires parallel to the drill hole cut off 
at the surface of the bone. (d). Insertion of the CMC-C compound 
with or without Colloss E. (e). Closing of wound with sutures in 
both periost and skin. 
Specimen Embedding 
  The drill defect was manually identified using the 
guidewires parallel to the defect. Using a Proxxon Micro 
Bandsaw (Greenville, Wisconsin, USA) the region of 
interest, including the guidewires, was cut out for further 
embedding. The specimens were dehydrated in a graded 
series of ethanol (70%-99%) and embedded in 
methylmethacrylate. 
CT 
  After embedding, the bone specimens were scanned by 
high-resolution  μCT scanning (-CT 40, Scanco Medical 
AG, Zürich, Switzerland). Cylindrical ROIs of 5 mm and 10 
mm in diameter, both with a depth of 8 mm, were chosen. 
The 5 mm ROI was placed in the center of the drill hole 
while the 10 mm ROI covered the entire hole. The 
cylindrical ROIs were found using the guide wires as 
markers parallel to the drill holes. The scanned images were 
rendered in three-dimensional (3D) reconstruction and 
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computional algorithms were used to calculate BMD and 
bone volume fractions (BV/TV). 
Histomorphometry 
  The blocks were cut into sections with a random starting 
point between 0-800 m from the top of the drill hole. Five 
sections were chosen with 1600 m intervals from the 
starting point and throughout the length of the drill defect. 
The thickness of the sections ranged between 40-50 m. 
Specimens were colored with toluidine blue, which stains 
woven bone dark blue and lamellar bone light blue. 
Intertrabecular space remains uncolored. Blinded 
quantitative histomorphometry was performed using the 
stereological software C.A.S.T. Grid (Olympus Denmark 
AS, Ballerup, Denmark). With the aid of the software, the 
ROI was defined. In the region, volume fractions of new 
bone and intertrabecular space were quantified by point 
counting technique. 
Statistics 
  For correlation comparison between analysis methods, 
linear regression analysis was used and correlation 
coefficient (r
2) was calculated using STATA software (9.0 
software (StataCorp LP, College Station, TX, USA). 
RESULTS 
  No complications were observed during surgery and all 
animals completed the observation period uneventfully. 
CT 
  Mineralization parameters measured by CT show higher 
BMD and BV/TV values for both animals in the CMC-C + 
Colloss E group after 16 weeks compared to the CMC-C 
group. After 16 weeks, a 13% and 15% increase in BV/TV 
respectively, were observed in the intervention group when 
compared to the CMC-C control group (Fig. 2). No 
differences between the intervention and control groups were 
seen after eight and twelve weeks. When comparing bone 
formation in the whole defect (Ø = 10mm) with the center 
part of the defect (Ø = 5mm) for all defects in the CMC-C + 
Colloss E group, we found BV/TV to be significantly lower 
in the center part compared to the whole defect by 12 %   
(p < 0.001). There was no significant difference in center 
part ROI BV/TV when all control group defects was 
compared to all defects in the intervention group (p = 0.37) 
(data on comparison between ROI 5 mm and ROI 10 mm not 
shown). 
QCT 
 Contrary  to  the  CT results, the QCT data suggested no 
difference in BMD between the two groups at any time point 
(Fig.  2), although not significant. Little difference was 
shown in density between the groups at 8 and 12 weeks. The 
BMD only increased slightly after an observation period of 
16 weeks, which was the case for both groups (Fig. 2). The 
QCT BMD data correlated with the BMD data from the CT 
scans with an R
2 = 0.804 (Fig. 3). 
Histomorphometry 
  Compared to the CMC-C grafted drill defect, the CMC-C 
+ Colloss E treated drill defect showed a higher BV/TV in 
the 16 week group, which correlates with the CT data. The 
increase in BV/TV after 16 weeks was 17 and 32 % 
respectively, in favor of the CMC-C + Colloss E group (Fig. 
2). Correlation between the histological observations and 
CT (Fig. 4) were found to be strong with a correlation 
coefficient, R
2 of 0.8935. The average percentage difference 
was found to be 8.2% between BV/TV measured with CT 
and histomorphometry, with histomorphometry resulting in 
the highest values. New bone formation was primarily 
located in the circumference of the bone defect. New bone 
seemed to be formed from the walls of the drill hole and 
 
Fig. (2). Graphs illustrating the BMD and BV/TV data from QCT, CT and histomorphometry. The BMD from the CT data increase after 
16 weeks in the Colloss E group, data that cannot be reproduced in the QCT data. The BMD does not vary between 8 and 12 weeks and no 
difference is observed between the two groups. This is the case for both the CT and the QCT data. The BV/TV in the bottom two graphs 
show a similar trend between histomorphometry and CT. There is no difference in BV/TV between 8 and 12 weeks and no increased 
BV/TV between control- an intervention group. At 16 weeks both CT and histomorphometry data show an increased BV/TV in the CMC-C 
+ Colloss E group compared to the CMC-C group. 184    The Open Orthopaedics Journal, 2010, Volume 4  Jensen et al. 
inwards and a multilocular reossification could not be 
observed. In most of the drill holes, the inner part was still 
only marrow space as illustrated in the comparative 
illustration between histological sections and CT 3d 
reconstructions in Fig. (5). After 8 weeks, bone formation 
was primarily appositional on the defect walls in the CMC-C 
group. In the Colloss E group, intramembranous bone 
formation was the major mechanism observed but strictly 
situated to the periphery of the defect (Fig. 5A, B). After 12 
weeks, new woven bone was visible almost throughout the 
defect and lamellar bone was being formed by remodeling 
close to the edges of the defects in the CMC-C + Colloss E 
group. In the CMC-C group, no or little lamellar bone was 
present and woven bone was not present in nearly the same 
amounts as in the intervention group (Fig. 5C, D). The same 
morphologies were present after 16 weeks but the 
discrepancy in lamellar bone were more distinct at this time-
point between the groups favoring the CMC-C + Colloss E 
filled defects. Furthermore, newly formed trabecular bone 
was present in the periphery of the intervention group 
defects (Fig. 5E, F). 
 
Fig. (3). Graph illustrating the correlation between the bone mineral 
density measured by QCT and CT. The values given by the 
evaluation software on the machines are given in different units. 
The Correlation between QCT and CT data shows strong relation 
between the two data-sets. 
 
Fig. (4). Graph illustrating correlation between BV/TV from CT 
and histomorphometry. The correlation between the data was 
satisfactory although with a systematic overrepresentation of Bone 
Volume in the histomorphometry data. 
 
DISCUSSION 
  This study revealed a late-onset bone regenerative effect 
of Colloss E. The bone healing was the same for both the 
intervention and the control group until after 16 weeks where 
the results suggests increased bone healing in the 
intervention group. The osteoinductive effect of Colloss E 
has been validated in previous studies and with earlier onset 
of the bone regenerative effect, which would indicate a 
delayed response from the osteogenic compounds known to 
be present in the lyophilizate. This could be due to an 
encapsulation of the osteoinductive components by the 
CMC-C. Many osteogenic compounds are using carriers to 
slow the release or act as fillers [21, 25]. One of the most 
widely used is collagen type-1, which is primarily known for 
its use as a carrier for commercially available BMP-2 
(INFUSE, Medtronic Sofamor Danek, Memphis, TN, USA) 
[26, 27]. Previous studies however do not suggest such an 
effect from the carriers selected. The mixture of collagen 
type-1 and CMC in weight ratio 2:1 has previously proven to 
be a favorable carrier for osteogenic protein-1 (rhOP-1) [28]. 
The choice of a mixture between CMC and Collagen type-1 
in weight ration 1:1 was based on these previous findings as 
well as the favorable viscous properties of CMC when added 
to a liquid such as whole blood. This mixture was added to 
increase the volume of the compound, and thereby distribute 
the bioactive lyophilisate evenly in the defect, minimize 
spillover to adjacent tissue and improve handling. These 
qualities were met with the exception of bone formation 
activity throughout the drill defect. By adding CMC-C to 
Colloss E, we expected the osteoinductive effect to increase 
in the center of the drill defect. By applying a more regular 
distribution of Colloss E within the bone defect during the 
biodegradation of the carrier, we expected small patches of 
carrier and Colloss E to be trapped within the newly formed 
bone and thereby facilitate a centripetal ossification with 
developing multilocular ossification sites progressing from 
the periphery of the drill defect towards the center. The 
results did however not cause any increased bone formation 
in the central part of the defect with a non-significant 
difference between control and intervention group BV/TV in 
the 5 mm center ROI. This leads to the suggestion that the 
CMC-C carrier is unable to facilitate multilocular 
reossification within the defect as seen when 
osteoconductive material or high dose BMP-2 is added to a 
bone defect [21]. A recent study have been investigating the 
addition of an osteoconductive component to Colloss E. 
Nienhuijs et al. used -TCP granules in addition to Colloss E 
in a goat mandible defect and although bone formation was 
observed around the -TCP granules in the central part of the 
defect, significantly less bone was present when compared to 
an empty defect and a defect with Colloss E alone [29]. The 
lack of new bone formation was explained by a high degree 
of inflammation partly due to foreign body reactions and 
excessive growth factor stimulation caused by the Colloss E. 
The use of CMC-C could potentially minimize this undesired 
effect by acting as a slowly degrading reservoir for the 
osteoinductive factors in the Colloss E matrix, minimize 
foreign body reaction and swelling, and thereby enable the 
use of an osteoconductive component in conjunction with 
Colloss E. The amount of Colloss E used in this study is 
important to take into  consideration.  Previous  studies  have  
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Fig. (5). Comparison of representative histological slices with 3-dimensional reconstructions of the drill defects for control and intervention 
group at all three time points. In the histological, the bone is colored blue with toluidine blue staining. The images show approximately 80% 
of the drill hole. The drill hole is easily recognizable with its uncolored marrow space surrounded with blue colored bone. In the CMC-C 
group, no or little bone formation is present (A), whereas peripheral membranous bone formation is visible in the CMC-C + Colloss E group 
(B). After 12 weeks, lamellar bone formation was observed at the edges of the defect in the intervention group and woven bone was present 
throughout the outer parts of the defect (D). No lamellar bone was observed in the control group (C). After 16 weeks, lamellar bone in newly 
formed trabecular bone structures was visible in the periphery of the intervention group bone defect and new bone was observed almost 
throughout the defect (F). The trabecular formation was less extensive in the control defect (E). There was no multilocular reossification 
present at any time point. The 3D reconstruction supports these observations on the right side of the illustration. Bars between the two 
columns represent 2 mm on the CT reconstructions and 1,2 mm on the histological images. 
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used double the amount of Colloss E in  the  same  size  bone 
defect [19, 21]. The concentration of growth factor may 
thereby be in sub effectual quantities for rapid onset of bone 
formation and early osteogenic response and the insufficient 
short-term effect further enhanced by retention of growth 
factor within the filler material. Collagen is also known to 
have a role in the differentiation of immature mesenchymal 
stem cells into osteoblasts in itself, which could result in a 
positive osteogenic effect in the control group and thereby 
masking the effect of Colloss E [30]. 
  The histological methods are considered gold standard 
for measuring bone volume to total volume. However, many 
other analytical methods are available to validate the 
histological findings as well as providing additional data 
regarding three dimensional bone structure and trabecular 
morphology. It is, however important to notice the 
limitations of these methods when correlating to traditional 
histological data. CT is known to underestimate bone 
volumes when small quantities of bone are found. 
Furthermore  CT overestimates bone volume when large 
quantities are present [31]. In this study we found strong 
correlation between BV/TV measurements from CT and 
histomorphometry (R
2  = 0.8935). However, we found an 
average difference of 8,2% with histomorphometry analysis 
resulting in a higher BV/TV. This phenomenon could be due 
to section thickness bias. With histological sections ranging 
in thickness from 40 to 50 m the chance of systematic 
overestimation is present. Tissue over projection occurs at 
the interface between two tissues of different opacity, where 
the more opaque tissue will be over projected. This will 
cause a systematic overestimation of the volume fraction of 
the more opaque tissue. This phenomenon is directly related 
to section thickness and inversely related to size structure 
[32]. This bias could be avoided in future studies by 
choosing thinner sections. 
  The limitations of the study are mainly caused by the 
limited amount of animals in each group. This excludes 
statistically significant results from the differences in bone 
volumes and mineral densities to be concluded. Furthermore 
the lack of a positive control, such as autograft, leaves an 
important comparison unanswered. Instead this study sheds 
light on future approaches, which could lead to a more 
homogenous and prolonged bone regenerative effect when 
DBMs are used to heal bone defects. 
CONCLUSION 
  This study evaluated the possibility to mix the 
osteoinductive bone matrix lyophilisate, Colloss E, with a 
high viscosity filler material, The resuslts suggests an 
increased osteogenic effect of the CMC-C + Colloss E after 
16 weeks. There was no increased bone formation in the 
center of the defect in the CMC-C Colloss E groups when 
compared to the CMC-C group. The bone quantity methods 
used in the study correlated with each other and proved 
consistent in showing equivalent results. 
DISCLOSURE 
  Unconditional supply of COLLOSS E and Collagen by 
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